RESECTION COMBINED WITH INTRAOPERATIVE RADIATION-THERAPY (IORT) FOR STAGE IV (TNM) GALLBLADDER CARCINOMA

被引:66
作者
TODOROKI, T
IWASAKI, Y
ORII, K
OTSUKA, M
OHARA, K
KAWAMOTO, T
NAKAMURA, K
机构
[1] UNIV TSUKUBA,INST CLIN MED,DEPT RADIOL,TSUKUBA,IBARAKI 305,JAPAN
[2] UNIV TSUKUBA,INST BASIC MED,DEPT PATHOL,TSUKUBA,IBARAKI 305,JAPAN
关键词
D O I
10.1007/BF01658729
中图分类号
R61 [外科手术学];
学科分类号
摘要
From October 1976 to May, 1990, a total of 86 patients with stage IV (TNM) gallbladder cancer were treated at Tsukuba University Hospital. Twenty-seven of the 86 patients underwent tumor resection; 43 patients received palliative surgery. The remaining 16 were too advanced to have surgery. Of 27 patients who had tumor resection, 9 had resection alone, 17 had intraoperative radiation therapy (IORT) +/- postoperative external radiotherapy (ERT), and 1 had postoperative ERT. The procedures used were: extended right hepatic lobectomy plus hepaticobiliary resection (HBR) (n = 2), hepatic segmentectomy (SIVb, SV) plus HBR (n = 9), hepatic segmentectomy (SIV, V, VI) with HBR (n = 1), hepatic segmentectomy (SIV, V) plus HBR with pancreaticoduodenectomy (PD) (n = 3), PD plus HBR (n = 1), cholecystectomy with wedge resection of the gallbladder fossa plus HBR (n = 3), and cholecystectomy plus HBR (n = 3), and cholecystectomy (n = 4). Regional lymph node dissections were performed in every patient and 17 of 27 patients underwent additional resections of adjacent organs such as the stomach, duodenum, colon, and abdominal wall. A single dose of 20-30 Gy was delivered intraoperatively for 17 patients. A mean total dose of 36.4 Gy (1.8/fraction) was added to IORT for 10 patients. The three-year cumulative survival rate was 10.1% for resection plus IORT but 0% for resection alone. The longest survivor is alive and well at 3 years and 3 patients are alive 16, 13, and 4 months after tumor resection followed by IORT plus ERT.
引用
收藏
页码:357 / 366
页数:10
相关论文
共 35 条
[1]   MAJOR AND MINOR SEGMENTECTOMIES REGLEES IN LIVER SURGERY [J].
BISMUTH, H ;
HOUSSIN, D ;
CASTAING, D .
WORLD JOURNAL OF SURGERY, 1982, 6 (01) :10-24
[2]  
BOSSET JF, 1989, CANCER, V64, P1843, DOI 10.1002/1097-0142(19891101)64:9<1843::AID-CNCR2820640915>3.0.CO
[3]  
2-N
[4]   ANALYSIS OF FAILURE FOLLOWING CURATIVE IRRADIATION OF GALLBLADDER AND EXTRAHEPATIC BILE-DUCT CARCINOMA [J].
BUSKIRK, SJ ;
GUNDERSON, LL ;
ADSON, MA ;
MARTINEZ, A ;
MAY, GR ;
MCILRATH, DC ;
NAGORNEY, DM ;
EDMUNDSON, GK ;
BENDER, CE ;
MARTIN, JK .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1984, 10 (11) :2013-2023
[5]  
FAIM RB, 1962, ANN SURG, V156, P114
[6]   CARCINOMA OF THE EXTRAHEPATIC BILIARY SYSTEM - RESULTS OF PRIMARY AND ADJUVANT RADIOTHERAPY [J].
FIELDS, JN ;
EMAMI, B .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1987, 13 (03) :331-338
[7]  
GEHAN EA, 1965, BIOMETRIKA, V52, P203, DOI 10.1093/biomet/52.1-2.203
[8]  
HANNA SS, 1978, CAN MED ASSOC J, V118, P59
[9]  
HERMANEK P, 1987, TNM CLASSIFICATION M, P56
[10]  
Hishikawa Y, 1983, Radiat Med, V1, P326